IL114059A0 - Phenethanolamine derivatives pharmaceutical compositions containing them process for their preparation and their use - Google Patents

Phenethanolamine derivatives pharmaceutical compositions containing them process for their preparation and their use

Info

Publication number
IL114059A0
IL114059A0 IL11405995A IL11405995A IL114059A0 IL 114059 A0 IL114059 A0 IL 114059A0 IL 11405995 A IL11405995 A IL 11405995A IL 11405995 A IL11405995 A IL 11405995A IL 114059 A0 IL114059 A0 IL 114059A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
phenethanolamine derivatives
derivatives pharmaceutical
Prior art date
Application number
IL11405995A
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9411589A external-priority patent/GB9411589D0/en
Priority claimed from GBGB9504169.5A external-priority patent/GB9504169D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL114059A0 publication Critical patent/IL114059A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
IL11405995A 1994-06-09 1995-06-08 Phenethanolamine derivatives pharmaceutical compositions containing them process for their preparation and their use IL114059A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9411589A GB9411589D0 (en) 1994-06-09 1994-06-09 Chemical compounds
GBGB9504169.5A GB9504169D0 (en) 1995-03-02 1995-03-02 Chemical compounds

Publications (1)

Publication Number Publication Date
IL114059A0 true IL114059A0 (en) 1995-10-31

Family

ID=26305035

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11405995A IL114059A0 (en) 1994-06-09 1995-06-08 Phenethanolamine derivatives pharmaceutical compositions containing them process for their preparation and their use

Country Status (5)

Country Link
AU (1) AU2737295A (en)
CO (1) CO4410319A1 (en)
IL (1) IL114059A0 (en)
PE (1) PE14696A1 (en)
WO (1) WO1995033724A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9525121D0 (en) * 1995-12-08 1996-02-07 Glaxo Group Ltd Chemical compounds
GB9525177D0 (en) * 1995-12-08 1996-02-07 Glaxo Group Ltd Chemical compounds
US5914339A (en) * 1996-05-14 1999-06-22 American Home Products Corporation Substituted 1,3-benzodioxoles
FR2751646B1 (en) * 1996-07-23 1999-01-22 Sanofi Sa PHENOXYPROPANOLAMINE WITH ANTAGONIST BETA3-ADRENERGIC ACTION
GB9706707D0 (en) * 1997-04-02 1997-05-21 Glaxo Group Ltd Chemical compounds
GB9812709D0 (en) * 1998-06-13 1998-08-12 Glaxo Group Ltd Chemical compounds
GB9929118D0 (en) * 1999-12-10 2000-02-02 Glaxo Group Ltd Chemical compounds
US7034053B2 (en) 2001-01-31 2006-04-25 Smithkline Beecham Corporation Phenethanolamine derivatives, compositions, and their use as agonists at atypical beta-adrenoreceptors
GB0102408D0 (en) * 2001-01-31 2001-03-14 Glaxo Group Ltd Chemical compounds
US7709677B2 (en) 2001-01-31 2010-05-04 Glaxosmithkline Llc Process of preparing arylethanoldiamines
GB0102407D0 (en) 2001-01-31 2001-03-14 Glaxo Group Ltd Process
NZ540698A (en) 2002-12-24 2008-05-30 Astrazeneca Ab Phosphonooxy quinazoline derivatives and their pharmaceutical use
EP1595873A1 (en) * 2004-05-13 2005-11-16 Boehringer Ingelheim Pharma GmbH & Co.KG Substituted cycloalkyl derivatives for the treatment of respiratory diseases
US7423035B2 (en) 2004-05-13 2008-09-09 Boehringer Ingelheim International Gmbh Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament
DK2484680T3 (en) 2005-12-07 2013-09-08 Basilea Pharmaceutica Ag Useful combinations of monolactam antibiotics with beta-lactamase inhibitors
US9907767B2 (en) 2010-08-03 2018-03-06 Velicept Therapeutics, Inc. Pharmaceutical compositions and the treatment of overactive bladder
US9522129B2 (en) 2010-08-03 2016-12-20 Velicept Therapeutics, Inc. Pharmaceutical Combination
KR20170086659A (en) 2014-12-03 2017-07-26 벨리셉트 테라퓨틱스, 인크. Compositions and methods of using modified release solabegron for lower urinary tract symptoms
FI3365321T3 (en) 2015-10-23 2024-01-02 B3Ar Therapeutics Inc Solabegron zwitterion and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154761A (en) * 1976-02-09 1979-05-15 Allen & Hanburys Limited Pharmacologically active compounds
DK31578A (en) * 1977-02-03 1978-08-04 Allen & Hanburys Ltd PROCEDURE FOR THE PRODUCTION OF BENZENE DERIVATIVES
US5061727A (en) * 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
NO179246C (en) * 1991-11-20 1996-09-04 Sankyo Co Aromatic amino-alcohol derivatives and intermediates for their preparation
GB9207964D0 (en) * 1992-04-10 1992-05-27 Ici Plc Chemical compounds

Also Published As

Publication number Publication date
PE14696A1 (en) 1996-05-13
WO1995033724A1 (en) 1995-12-14
AU2737295A (en) 1996-01-04
CO4410319A1 (en) 1997-01-09

Similar Documents

Publication Publication Date Title
IL113625A0 (en) Amino acid derivatives processes for their preparation and pharmaceutical compositions containing them and their use
HK1005136A1 (en) Amido-3-pyrazole derivatives process for their preparation and pharmaceutical compositions containing them
IL114578A0 (en) Amino purine-béta-D ribofuranuronamide derivatives their preparation pharmaceutical compositions containing them and their use
IL115039A (en) Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them
ZA9510146B (en) Novel perhydroisoindole derivatives processes for their preparation and pharmaceutical compositions comprising them
IL114795A (en) N-benzylindole-and benzopyrazole derivatives their preparation and pharmaceutical compositions containing them
IL115905A0 (en) Sordarin derivatives their preparation and pharmaceutical compositions containing them
IL114059A0 (en) Phenethanolamine derivatives pharmaceutical compositions containing them process for their preparation and their use
IL119559A0 (en) Purin -6- one derivatives their preparation and pharmaceutical compositions containing them
IL115072A0 (en) Substituted 4-phenyl-6-amino-nicotinic acid derivatives their preparation pharmaceutical compositions containing them and their use
HUP9901485A2 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
IL112936A0 (en) Quinolone - and - naphthyridone - carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
CZ92295A3 (en) Boronpeptide derivatives, process of their preparation and pharmaceutical composition containing thereof
HUT77375A (en) Enterokinetic benzamides, pharmaceutical compositions containing the same and process for their preparation
IL116190A (en) Eleutherobin, analogs thereof and pharmaceutical compositions containing them
ZA9511029B (en) Substituted 4-phenylthiazole derivatives process for their preparation and pharmaceutical compositions containing them
AP9600784A0 (en) Oxathiolanes method for their preparation and pharmaceutical compositions containing them
IL115272A0 (en) Asp-pallidipin pharmaceutical compositions containing the same and processes for the preparation thereof
IL114623A0 (en) Substituted triazolylmethylphenylnaph-thyridones their preparation and pharmaceutical compositions containing them
ZA948689B (en) New taxicin derivatives their preparation and pharmaceutical compositions containing them
HUP9801068A3 (en) 1,2,3,4-tetrahydro-2-naphtaleneamine derivatives, process for their preparation, their use, and pharmaceutical compositions containing them
ZA963350B (en) Cycloheaxane compounds process for their preparation and pharmaceutical compositions containing them
IL115732A (en) Antiarrhythmic substituted nitrobenzamides process for their preparation uses thereof and pharmaceutical compositions containing them
IL119603A0 (en) Amidinohydrazone derivatives methods for the preparation thereof and pharmaceutical compositions containing the same
IL113415A0 (en) Dihydrodibenzoquinolinediones their preparation and use and pharmaceutical compositions containing them